This article is part of our online news archive

Congratulations Chris Thomas on his TSB feasibility project

Professor Chris Thomas has been awarded a Technology Strategy Board with BBSRC: Advancing the industrial application of synthetic biology - Feasibility Study Project – "Synthetic Biology to Improve Antibiotic Production" with Glaxo SmithKline (GSK).

University of Birmingham Aston Webb building

Professor Chris Thomas has been awarded a Technology Strategy Board with BBSRC: Advancing the industrial application of synthetic biology - Feasibility Study Project – “Synthetic Biology to Improve Antibiotic Production” with Glaxo SmithKline (GSK).

thomas-chris

In the video below Professor Thomas describes his research in 60 seconds

Video transcript here